Published in: Research Studies Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial Author admin Published on: January 24, 2023 Powered By EmbedPress
8 months ago Research Studies Exploring the Science: How Research Supports Semaglutide for Weight Loss
2 years ago Research Studies Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity Obstructive sleep apnea is characterized by disordered breathing during sleep and is associated with major cardiovascular complications; excess adiposity is an etiologic risk factor. Tirzepatide may be a potential treatment.